Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Standard Biotools Inc (LAB)

Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Standard Biotools Inc 2 Tower Place Ste 2000 South San Francisco CA 94080 USA

www.standardbio.com Employees: 539 P: 650-266-6000 F: 650-871-7152

Description:

Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 718,460
Enterprise Value, $K 986,420
Shares Outstanding, K 372,259
Annual Sales, $ 106,340 K
Annual Net Income, $ -74,660 K
Last Quarter Sales, $ 44,970 K
Last Quarter Net Income, $ -26,940 K
EBIT, $ -163,810 K
EBITDA, $ -147,860 K
60-Month Beta 1.61
% of Insider Shareholders 53.10%
% of Institutional Shareholders 53.74%
Float, K 174,589
% Float 46.90%
Short Volume Ratio 0.40

Growth:

1-Year Return -13.17%
3-Year Return -49.61%
5-Year Return -42.22%
5-Year Revenue Growth -5.86%
5-Year Earnings Growth 27.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 10/30/24
Next Earnings Date N/A
Earnings Per Share ttm -0.53
EPS Growth vs. Prev Qtr 33.33%
EPS Growth vs. Prev Year 68.42%
Annual Dividend Yield 0.00%
Dividend Payable Date 07/29/03
Dividend Payout Ratio 0.00%

LAB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -27.05%
Return-on-Assets % -15.51%
Profit Margin % -70.21%
Debt/Equity 0.00
Price/Sales 6.37
Price/Cash Flow N/A
Price/Book 1.38
Book Value/Share 1.32
Interest Coverage -15.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar